clinical

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Articles

A study including data from about 42,000 eyes found diabetic retinopathy (DR) severity is a risk factor for the progression of diabetic eye disease. Other findings support the idea that genetic factors influence the development of proliferative DR versus diabetic macular edema. 



Research suggests course of diabetic eye disease influenced by genetic factors

Study highlights the role of demographic and socioeconomic characteristics as contributors to disease- and treatment-related disparities among patients with diabetic macular edema.

Identifying gaps in anti-VEGF treatment among minorities with DME

Podcasts

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

Integrating AI to manage DR in a primary care setting

Videos

A panel of experts in ophthalmology and optometry review the diagnosis and treatment of diabetic eye disease including emerging agents in the field.

Updates in DME, diabetic retinopathy

Results support further research investigating transforming growth factor-β-Induced Gene Human Clone 30 (BIGH3).

Exploring pathogenic cytokines as biomarkers for DME

The benefit is robust across a variety of demographics and baseline disease characteristics, according to data.

Aflibercept broadly effective for reducing DR severity in post-hoc analysis 

Study offers a real-world scenario of a very specific, but frequent and crucial aspect of the care of patients with diabetes, suggests clinician


Researchers advocate for intraoperative intravitreal steroid during cataract surgery in DME eyes

Visual acuity outcomes at 6 months’ post-treatment were similar, regardless of the use of anti-VEGF therapy. 

Probe of IRIS Registry shows anti-VEGF injections leading treatment for PDR 

Results could provide a new preferred treatment paradigm for this population

FA implant outperforms anti-VEGF in DR patients lost-to-follow-up

Study explores correlations between functional and structural tests 

Diabetic Retinopathy